Trade Mark Journal No.2024/040 4 October 2024
WO0000001810339 (5)
Office of origin: United States of America
Date of International Registration:1 July 2024
Date of designation in the UK:
1 July 2024

International priority date claimed: 19 January 2024
(United States of America)
(98366670)
- Class 5
- Pharmaceutical and therapeutic preparations for the treatment of vascular, inflammatory, and neurological diseases and disorders.
Therini Bio, Inc.
Representative: Jessica L. Rothstein Goodwin Procter LLP, 620 Eighth Avenue, New York NY 10018, UNITED STATES OF AMERICA